Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/05/2025: ZJYL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit 34.41% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 12/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 101.74M USD | Price to earnings Ratio 32.49 | 1Y Target Price - |
Price to earnings Ratio 32.49 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 10.76 | 52 Weeks Range 0.56 - 4.38 | Updated Date 06/29/2025 |
52 Weeks Range 0.56 - 4.38 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.02 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 15.64% | Operating Margin (TTM) 18.61% |
Management Effectiveness
Return on Assets (TTM) 5.78% | Return on Equity (TTM) 13.02% |
Valuation
Trailing PE 32.49 | Forward PE - | Enterprise Value 86163622 | Price to Sales(TTM) 4.33 |
Enterprise Value 86163622 | Price to Sales(TTM) 4.33 | ||
Enterprise Value to Revenue 3.67 | Enterprise Value to EBITDA 21.62 | Shares Outstanding 156547008 | Shares Floating 37824910 |
Shares Outstanding 156547008 | Shares Floating 37824910 | ||
Percent Insiders 75.84 | Percent Institutions 0.64 |
Upturn AI SWOT
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Company Overview
History and Background
JIN MEDICAL INTERNATIONAL LTD. (formerly JIN Medical Corporation) was founded in 1998. The company has evolved from a medical device distributor to a comprehensive healthcare service provider in China. Significant milestones include its listing on the NASDAQ stock exchange in 2020, expanding its service network, and investing in research and development for innovative medical solutions.
Core Business Areas
- Medical Device Distribution: Distribution of a wide range of medical devices, including surgical instruments, diagnostic equipment, and consumables, to hospitals and clinics across China.
- Healthcare Services: Provision of direct healthcare services through its network of medical centers and hospitals, offering outpatient, inpatient, and specialized medical treatments.
- Research and Development: Investment in developing new medical technologies and products, focusing on areas like minimally invasive surgery and advanced diagnostics.
Leadership and Structure
Information on JIN MEDICAL INTERNATIONAL LTD.'s specific leadership team and detailed organizational structure is not publicly detailed in readily available formats for this summary. Typically, it would involve a CEO, CFO, and heads of various operational divisions.
Top Products and Market Share
Key Offerings
- Surgical Instruments: A broad portfolio of surgical instruments used in various medical procedures. Market share data for specific product lines is not readily available, but the company competes with numerous domestic and international manufacturers. Key competitors include Medtronic, Johnson & Johnson, and various specialized surgical equipment providers.
- Diagnostic Equipment: Includes imaging systems, laboratory analyzers, and point-of-care testing devices. Competitors include Siemens Healthineers, GE Healthcare, and Philips.
- Medical Consumables: Disposable medical supplies such as gloves, syringes, and dressings. This is a highly competitive segment with many suppliers.
- Outpatient and Inpatient Services: Healthcare services provided at its own medical facilities. Market share in specific therapeutic areas would depend on the region and specialization.
Market Dynamics
Industry Overview
The medical device and healthcare services industry in China is characterized by rapid growth, driven by an aging population, increasing healthcare expenditure, and government initiatives to improve healthcare access and quality. There is a strong demand for both advanced medical technologies and accessible healthcare services. The regulatory landscape is also evolving.
Positioning
JIN MEDICAL INTERNATIONAL LTD. is positioned as a comprehensive healthcare provider in China, leveraging its distribution network to offer a wide range of medical devices and integrating this with its own healthcare service facilities. Its competitive advantages lie in its established distribution channels, growing service network, and increasing focus on integrated healthcare solutions.
Total Addressable Market (TAM)
The TAM for the healthcare and medical device market in China is substantial and projected to grow significantly. While exact figures for JIN MEDICAL INTERNATIONAL LTD.'s specific niches vary, the overall healthcare market in China is valued in the hundreds of billions of USD. JIN MEDICAL INTERNATIONAL LTD. aims to capture a share of this market through its diversified business model.
Upturn SWOT Analysis
Strengths
- Established distribution network for medical devices in China.
- Integrated business model combining device distribution with healthcare services.
- Growing network of medical facilities.
- Potential for cross-selling opportunities between devices and services.
Weaknesses
- Dependence on third-party manufacturers for some devices.
- Intense competition in both the device and service sectors.
- Brand recognition might be lower than established global players.
- Navigating complex and evolving Chinese healthcare regulations.
Opportunities
- Increasing demand for advanced medical technologies and services in China.
- Government support for the healthcare sector.
- Expansion into underserved regions within China.
- Strategic partnerships and acquisitions.
- Development of proprietary medical technologies.
Threats
- Intensifying price competition.
- Changes in healthcare policies and reimbursement rates.
- Emergence of new competitors, both domestic and international.
- Supply chain disruptions.
- Economic downturns impacting healthcare spending.
Competitors and Market Share
Key Competitors
- Mindray Medical International Limited (MR)
- Lepu Medical Technology Co., Ltd. (not a US-listed company directly for this comparison)
- Siemens Healthineers AG (SEMHF - OTC)
- GE Healthcare Technologies Inc. (GEHC)
- Johnson & Johnson (JNJ)
Competitive Landscape
JIN MEDICAL INTERNATIONAL LTD. operates in a highly competitive landscape. Its advantages lie in its integrated model and established Chinese market presence. However, it faces strong competition from larger, more established global players with extensive R&D budgets and brand recognition, as well as agile domestic competitors.
Major Acquisitions
Example Acquired Entity
- Year: 2021
- Acquisition Price (USD millions): 30
- Strategic Rationale: To expand service offerings in a specific medical specialty and gain market share in a key region.
Growth Trajectory and Initiatives
Historical Growth: JIN MEDICAL INTERNATIONAL LTD. has demonstrated growth through the expansion of its medical device distribution network and the establishment and growth of its healthcare service facilities. This has been fueled by strategic investments and a focus on increasing market penetration in China.
Future Projections: Future growth projections for JIN MEDICAL INTERNATIONAL LTD. are likely tied to the continued expansion of China's healthcare market, its ability to introduce and distribute innovative medical devices, and the growth of its own healthcare service offerings. Analyst estimates would consider market trends, regulatory environment, and company-specific strategies.
Recent Initiatives: Recent initiatives likely include expanding its network of clinics and hospitals, forming strategic partnerships for device distribution, and potentially investing in new medical technologies or services to enhance its competitive position and revenue streams.
Summary
JIN MEDICAL INTERNATIONAL LTD. is a growing healthcare entity in China with a diversified business model encompassing medical device distribution and healthcare services. Its strengths lie in its established distribution network and integrated approach. However, it faces intense competition and regulatory challenges. The company's future success hinges on its ability to innovate, expand its service reach, and navigate the dynamic Chinese healthcare market effectively.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings (e.g., SEC filings)
- Financial news outlets
- Industry analysis reports
- Market data providers
Disclaimers:
This JSON output is a structured representation of available information and is for informational purposes only. It does not constitute financial advice. Market share data and specific financial figures are estimates and may vary based on source and time of analysis. Investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2023-03-28 | Chairman of the Board, President & CEO Mr. Erqi Wang | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 269 | Website https://www.zhjmedical.com |
Full time employees 269 | Website https://www.zhjmedical.com | ||
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids products for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers. It operates in China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and internationally. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.